331 related articles for article (PubMed ID: 15282962)
1. Molecular detection of drug resistance in Mycobacterium leprae.
Williams DL; Gillis TP
Lepr Rev; 2004 Jun; 75(2):118-30. PubMed ID: 15282962
[No Abstract] [Full Text] [Related]
2. Drug-resistant leprosy: monitoring and current status.
Williams DL; Gillis TP
Lepr Rev; 2012 Sep; 83(3):269-81. PubMed ID: 23356028
[No Abstract] [Full Text] [Related]
3. Detection of gene mutations related with drug resistance in Mycobacterium leprae from leprosy patients using Touch-Down (TD) PCR.
Kim SK; Lee SB; Kang TJ; Chae GT
FEMS Immunol Med Microbiol; 2003 May; 36(1-2):27-32. PubMed ID: 12727362
[TBL] [Abstract][Full Text] [Related]
4. Analysis of drug-resistant strains of Mycobacterium leprae in an endemic area of Vietnam.
Kai M; Nguyen Phuc NH; Nguyen HA; Pham TH; Nguyen KH; Miyamoto Y; Maeda Y; Fukutomi Y; Nakata N; Matsuoka M; Makino M; Nguyen TT
Clin Infect Dis; 2011 Mar; 52(5):e127-32. PubMed ID: 21292655
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistant Mycobacterium leprae from patients with leprosy.
Maeda S; Matsuoka M; Nakata N; Kai M; Maeda Y; Hashimoto K; Kimura H; Kobayashi K; Kashiwabara Y
Antimicrob Agents Chemother; 2001 Dec; 45(12):3635-9. PubMed ID: 11709358
[TBL] [Abstract][Full Text] [Related]
6. Reverse line probe assay for the rapid detection of rifampicin resistance in Mycobacterium leprae.
Sapkota BR; Ranjit C; Macdonald M
Nepal Med Coll J; 2006 Jun; 8(2):122-7. PubMed ID: 17017404
[TBL] [Abstract][Full Text] [Related]
7. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.
Matsuoka M; Budiawan T; Aye KS; Kyaw K; Tan EV; Cruz ED; Gelber R; Saunderson P; Balagon V; Pannikar V
Lepr Rev; 2007 Dec; 78(4):343-52. PubMed ID: 18309708
[TBL] [Abstract][Full Text] [Related]
8. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea.
You EY; Kang TJ; Kim SK; Lee SB; Chae GT
J Infect; 2005 Jan; 50(1):6-11. PubMed ID: 15603834
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of folP1 mutations associated with clinical resistance to dapsone, in Mycobacterium leprae isolates from South Korea.
Lee SB; Kim SK; Kang TJ; Chae GT; Chun JH; Shin HK; Kim JP; Ko YH; Kim NH
Ann Trop Med Parasitol; 2001 Jun; 95(4):429-32. PubMed ID: 11454253
[No Abstract] [Full Text] [Related]
10. Possible mode of emergence for drug-resistant leprosy is revealed by an analysis of samples from Mexico.
Matsuoka M; Suzuki Y; Garcia IE; Fafutis-Morris M; Vargas-González A; Carreño-Martinez C; Fukushima Y; Nakajima C
Jpn J Infect Dis; 2010 Nov; 63(6):412-6. PubMed ID: 21099091
[TBL] [Abstract][Full Text] [Related]
11. Is drug-resistant Mycobacterium leprae a real cause for concern?: First approach to molecular monitoring of multibacillary Colombian patients with and without previous leprosy treatment.
Guerrero MI; Colorado CL; Torres JF; León CI
Biomedica; 2014 Apr; 34 Suppl 1():137-47. PubMed ID: 24968045
[TBL] [Abstract][Full Text] [Related]
12. [Drug resistance of Mycobacterium leprae].
Pattyn SR
Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
[No Abstract] [Full Text] [Related]
13. Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy.
Sekar B; Arunagiri K; Kumar BN; Narayanan S; Menaka K; Oommen PK
Lepr Rev; 2011 Mar; 82(1):36-45. PubMed ID: 21644470
[TBL] [Abstract][Full Text] [Related]
14. A drug-resistant leprosy case detected by DNA sequence analysis from a relapsed Mexican leprosy patient.
Lopez-Roa RI; Fafutis-Morris M; Masanori M
Rev Latinoam Microbiol; 2006; 48(3-4):256-9. PubMed ID: 18293659
[TBL] [Abstract][Full Text] [Related]
15. Primary multidrug-resistant leprosy, United States.
Williams DL; Hagino T; Sharma R; Scollard D
Emerg Infect Dis; 2013 Jan; 19(1):179-81. PubMed ID: 23260417
[No Abstract] [Full Text] [Related]
16. Search for effective short-course regimens for the treatment of leprosy.
Pattyn SR
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):76-81. PubMed ID: 8326183
[No Abstract] [Full Text] [Related]
17. A quantitative basis for sustainable anti-Mycobacterium leprae chemotherapy in leprosy control programs.
Almeida JG
Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):255-68. PubMed ID: 1522367
[No Abstract] [Full Text] [Related]
18. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.
Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V
Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335
[TBL] [Abstract][Full Text] [Related]
19. Detection of Mycobacterium leprae DNA by polymerase chain reaction in the blood of individuals, eight years after completion of anti-leprosy therapy.
Santos AR; Balassiano V; Oliveira ML; Pereira MA; Santos PB; Degrave WM; Suffys PN
Mem Inst Oswaldo Cruz; 2001 Nov; 96(8):1129-33. PubMed ID: 11784934
[TBL] [Abstract][Full Text] [Related]
20. Drug resistance in leprosy: lessons from past and future perspective.
Gupta UD; Katoch VM
Indian J Lepr; 1999; 71(4):451-63. PubMed ID: 10804973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]